Sharlene Day

Title: Sharlene Day - Innovator in Cardiac Performance Regulation

Introduction

Sharlene Day is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of cardiac performance through her innovative research and inventions. Her work focuses on regulating cardiac performance, which is crucial for addressing heart-related diseases.

Latest Patents

Sharlene Day holds a patent for "Compositions and methods for regulating cardiac performance." This invention relates to cardiac performance, particularly in regulating it via recombinant troponin I (TnI) protein and nucleic acids encoding recombinant TnI. The patent provides nucleic acids encoding gain of function TnI proteins, vectors containing such nucleic acids, host cells containing such vectors, transgenic animals carrying a gain of function TnI protein, and therapeutic agents for gene therapy of heart failure or disease.

Career Highlights

Sharlene Day is affiliated with the University of Michigan, where she conducts her research and development. Her work has garnered attention for its potential applications in therapeutic settings, particularly for heart failure and related conditions. She has been recognized for her innovative approach to cardiac performance regulation.

Collaborations

Sharlene collaborates with notable colleagues, including Joseph M Metzger and Margaret Westfall. These collaborations enhance her research efforts and contribute to the advancement of cardiac health solutions.

Conclusion

Sharlene Day's contributions to cardiac performance regulation through her patent and research at the University of Michigan highlight her role as an influential inventor in the medical field. Her work has the potential to significantly impact the treatment of heart diseases and improve patient outcomes.